Fibrillar Structure and Charge Determine the Interaction of Polyglutamine Protein Aggregates with the Cell Surface
Open Access
- 1 August 2012
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 287 (35) , 29722-29728
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Pathogenic protein seeding in alzheimer disease and other neurodegenerative disordersAnnals of Neurology, 2011
- Striatal-Enriched Protein Tyrosine Phosphatase Expression and Activity in Huntington's Disease: A STEP in the Resistance to ExcitotoxicityJournal of Neuroscience, 2011
- Protein aggregation and neurodegenerative diseaseNature Medicine, 2004
- Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolutionJournal of Molecular Medicine, 2003
- PROTOFIBRILS, PORES, FIBRILS, AND NEURODEGENERATION: Separating the Responsible Protein Aggregates from The Innocent BystandersAnnual Review of Neuroscience, 2003
- Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cellsHuman Molecular Genetics, 2002
- Lessons from animal models of Huntington's diseaseTrends in Genetics, 2002
- Solubilization and disaggregation of polyglutamine peptidesProtein Science, 2001
- Conformational diseaseThe Lancet, 1997
- BIOLOGY AND GENETICS OF PRION DISEASESAnnual Review of Microbiology, 1994